NDATOPICALSOLUTION
Approved
Jun 2014
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Mechanism of Action
12.1 Mechanism of Action JUBLIA topical solution is an azole antifungal [ see ]. 12.2 Pharmacodynamics The pharmacodynamics of JUBLIA is unknown. 12.3 Pharmacokinetics Systemic absorption of efinaconazole in 18 adult subjects with severe onychomycosis was determined after application of JUBLIA once…
Pharmacologic Class:
Azole Antifungal
Clinical Trials (1)
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Started Aug 2016
62 enrolled
Onychomycosis
Loss of Exclusivity
LOE Date
Apr 25, 2035
111 months away
Patent Expiry
Apr 25, 2035